Objectives: Self versus proxy perspectives may produce different results that are important for clinical decision-making and for assessing outcomes in research studies. We examined differences in child versus parent report of the child's health-related quality of life (HRQOL) in a large prospective, community-based study of newly diagnosed childhood epilepsy that included children with epilepsy (case) and sibling controls. Methods: HRQOL was assessed 8 to 9 years after initial diagnosis of epilepsy in a subset of 143 case-control matched pairs using the Child Health Questionnaire (CHQ), a generic HRQOL measure with child (CHQ-CF87), and parent (CHQ-PF50) versions. Results: There were no significant differences between self-reported case and sibling control HRQOL scores on 9 of 11 scales or 2 global items. Nevertheless, parent ratings were significantly better (higher HRQOL) for sibling controls compared with epilepsy cases on 10 of 12 scales, global behavior and general health items, and the physical and psychosocial summary scores (P Յ 0.05). Parent-child agreement was low for cases and controls (kappa 0.27-0.33) for three single-item questions with the same wording on parent and child versions. Parent ratings of the case's HRQOL were often significantly associated with 5-year remission status and current antiepileptic drug use, but the case's self-reported HRQOL scores were not. In contrast, current pharmacoresistance was often associated with the child and parent ratings of the child's HRQOL. Conclusion: Children with epilepsy report HRQOL that is comparable to that of sibling controls, while parents rate children with epilepsy as having lower HRQOL than sibling controls. Measuring outcomes in studies of this population should incorporate both perspectives.
Introduction
Epilepsy is one of the most common chronic neurological diseases, affecting approximately 1% of the population [1] . Approximately one-half of epilepsy in the population first occurs during childhood. Children with epilepsy face many challenges including but not limited to seizures; they often have learning, cognitive and school difficulties, medication side effects, social stigma, psychiatric comorbidity, and behavioral problems [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] . Given these challenges, it is important to measure healthrelated quality of life (HRQOL) in children with epilepsy. HRQOL assessments in children, however, are complex; although ideally elicited directly, proxy ratings are often used to assess HRQOL in young children. Children, however, may have different perspectives from that of their adult proxies. Identification of such potential differences is important for assessing outcomes in research studies and for developing comprehensive treatment programs for children and families with epilepsy.
Although a number of studies have evaluated HRQOL in children with epilepsy, the source of report for HRQOL often varies [13] [14] [15] [16] [17] [18] . Modi et al. reported that children with a single seizure, or with newly diagnosed untreated epilepsy, had significantly worse Pediatric Quality of Life Inventory (PedsQL) scores compared with general population norms [17] . Sabaz et al. reported that children with "symptomatic" epilepsy have worse HRQOL than those with idiopathic epilepsy using the Child Behavior Checklist (CBCL), the Child Health Questionnaire (CHQ), the Quality of life in Childhood Epilepsy (QOLCE), and the Child Seizure Profile (CSP) [18] . In both of these studies, HRQOL assessments were elicited by parent report only. Austin et al. showed that youths with epilepsy had worse HRQOL than youths with asthma; psychological, social, and school domains of QOL were measured using five different instruments with child, parent, or teacher report [13] . HRQOL for children with epilepsy has also been assessed by child report directly; studies by Devinsky et al. and Benavente-Aguilar et al. assessed self-report of HRQOL in adolescents with epilepsy using the Quality of Life in Epilepsy for Adolescents (QOLIE-AD 48) [15, 16] .
Few studies, however, have compared child and parent report of HRQOL in children with epilepsy. Verhey et al. compared parent and child report of HRQOL using the Health-Related Quality of Life Measure for Children with Epilepsy (CHEQOL-25), an epilepsy-targeted HRQOL measure [19] . Disagreement was observed between child and parent reports for subjective domains of HRQOL (secrecy and present worries); parent report of HRQOL was lower, or worse, on all domains compared with child report, with the exception of one domain, present worries. Similarly, in a sample of children with first-time seizures, Hamiwka et al. found that compared with normative data, parent report of HRQOL was lower on 6 out of 11 scales and 1 summary score on the CHQ, while children reported lower HRQOL on only the change in health item [20] . Additionally, in a sample of adolescents with epilepsy, Huberty et al. compared parent, child, and teacher behavioral ratings using the CBCL and found that mother's evaluations of their child's behavioral problems were significantly higher (or worse) than the youth's evaluations on 8 of 11 subscales [21] . Finally, although parent-child agreement was high (r Ն 0.5) in a sample of epilepsy patients using the German version of the PedsQL, the mean responses of child report of HRQOL were higher, or better, compared with parent report on all scales, with the exception of a school functioning domain [22] . These studies provide some preliminary support for the hypothesis that children and parents report HRQOL differently in children with epilepsy.
Understanding whether child versus parent perspectives produce different results is important for clinical decisionmaking and for planning research studies that focus on these outcomes, particularly in children with epilepsy. Furthermore, as children with epilepsy, or with other chronic diseases, become adults, recognition of these potential differences may be important for identifying those with special health needs requiring transition support [23] . We examined parent versus child report of HRQOL in a group of children with epilepsy and sibling controls to parent report of HRQOL in these children at longterm follow-up in a prospective, community-based cohort study of newly diagnosed epilepsy.
Methods

Sample
The Connecticut Study of Epilepsy is a prospective, communitybased cohort study that recruited 613 children with newly diagnosed epilepsy between 1993 and 1997 with ongoing prospective follow-up; details of methods, recruitment, and follow-up procedures have been published previously [24] . Initial enrollment inclusion criteria included initial diagnosis of epilepsy by participating physicians (or diagnosis by a nonparticipating physician with referral to a participating physician within 3 months of diagnosis) during the recruitment period (January 1993-December 1997) and first of two or more unprovoked seizures occurred between 1 month (28 days) through 15 years of age.
Eight to 9 years after initial enrollment (March 2002-February 2006), 311 subjects from the original cohort and family members of those subjects participated in a comprehensive reassessment protocol; siblings without a neurological disability, within 3 years of the patient's age and less than 18 years of age were also enrolled as controls [5] . The protocol included an assessment of HRQOL reported by the child with epilepsy (case) and a sibling control, and a parent's assessment of both the case and the sibling control's HRQOL.
Institutional review board approval was obtained at all sites (G07-07-094-University of California Los Angeles). Written informed consent was obtained from the parent and written assent from the child, at the time of initial enrollment and at the 8-to 9-year reassessment.
Data Collection
Clinical and demographic data of the cases and the parents were obtained via a structured in-person interview (clinic or subject's home) with the parent or guardian interviewed by trained research associates during initial enrollment [24] . This interview included details of the child's unprovoked or provoked seizures, medical, and developmental history. All baseline medical records were reviewed, and information including neurological examination, presence of mental retardation, neuroimaging findings, specific underlying etiology, history of prior provoked seizures, presence of other medical conditions, and electroencephalogram (EEG) findings were extracted and coded on an ongoing basis. The families were called every 3 to 4 months by trained research associates and asked whether their child had experienced any interval seizures, and information regarding the dates, types of seizures, and circumstances of any reported seizure, in addition to any changes in antiepileptic medications were ascertained. The patients and the families were asked to keep seizure logs. At the 8-to 9-year follow-up comprehensive reassessment, clinical and demographic data of the cases, the parents, and the sibling controls were obtained via a structured interview in-person (in a clinic or the subject's home) or via phone.
Measures
HRQOL was assessed using the CHQ, a self-administered, generic HRQOL measure with child (CHQ-CF87) and parent (CHQ-PF50) versions [25] . The CHQ-CF87 includes 87 items used to create 11 scales (physical function, role/social limitations-physical, role/social limitations-behavioral, role/ social limitations-emotional, mental health, self-esteem, behavior, bodily pain/discomfort, general health perceptions, family activities) and 2 global items (global behavior and global general health). The CHQ-PF50 includes 50 items used to construct 12 scales (physical function, role/social limitations-physical, role/ social limitations-emotional/behavioral, mental health, selfesteem, behavior, bodily pain/discomfort, general health perceptions, family activities, parent impact on time, parent emotional impact) and 2 global items (global behavior and global general health); two summary scores (physical and a psychosocial summary scores) can also be generated from the CHQ-PF50.
Raw scores for each scale are transformed to a 0 to 100 scale with 0 representing worst health and 100 indicating best health. Physical and psychosocial summary scores (CHQ-PF50 only) are transformed to T-scores (mean = 50, SD = 10) calculated against a general reference US population. The CHQ-CF87 and the CHQ-PF50 contain similar but not identical items, making direct score comparisons problematic except for three single-items that have similar wording.
To compare construct validity across the case and the parent versions, we examined associations of the case and the parentreported HRQOL measures with whether or not the child had been seizure-free for at least 5 years at the time of the follow-up reassessment, whether or not the child was currently taking antiepileptic drugs (AEDs), whether the child's epilepsy was associated with a known structural or metabolic underlying cause, or an electroclinical syndrome considered to be an epileptic encephalopathy, designated here as "complicated epilepsy" [26] , and whether or not the child's epilepsy was pharmacoresistant and the child was not seizure-free for the last 5 years. Pharmacoresistance was defined as the failure of two different appropriate AEDs to bring seizures under complete control when used as prescribed and pushed to the maximum tolerated levels [27] . This definition is consistent with that proposed by the Task Force of the International League Against Epilepsy Commission on Therapeutic Strategies [28] .
Analysis
Sociodemographic and clinical characteristics of the cases and the controls and the parents were compared using bivariate statistics (matched t-tests, Wilcoxon rank-sum, chi-square). We estimated internal consistency reliability (Cronbach's alpha) for each scale of the CHQ-CF87 and the CHQ-PF50 for the cases and the controls.
Because direct comparisons between child and parent CHQ versions were problematic, we compared self-reported HRQOL in the cases versus the sibling controls on the CHQ-CF87 and then parent-reported HRQOL in the cases versus the sibling controls on the CHQ-PF50. Only subjects for whom HRQOL was evaluated for both the case and the sibling control, and for whom HRQOL of the case and control were rated by the same parent (n = 143) were included in this matched analysis. Mean differences between the cases and the controls (child report and parent report) were calculated. We compared the case versus the control self-reported HRQOL means for the 11 scales and 2 global items of the CHQ-CF87 using matched or paired t-tests. Similar analyses were performed to compare parent report of the case versus the control HRQOL on the 12 scales, 2 global items, and 2 summary scores of the CHQ-PF50. A sensitivity analysis was performed excluding the 29 complicated cases, generally associated with more severe neurological impairment. To compare HRQOL responses to a reference healthy standard population, parent report of the case and the control mean HRQOL responses (CHQ-PF50) were compared with ageadjusted and gender-adjusted norms using t-tests [25] (childreported norms from a representative US population of healthy children are not available, thereby precluding a similar analysis for the CHQ-CF87).
To assess the level of parent-child agreement, we calculated weighted kappas between the case and the parent report of HRQOL between parent and child on the single items that had the same wording (bodily pain/discomfort, global general health, and global behavior) [29] .
We used a multitrait-multimethod matrix (MTMM) to assess the construct validity for the case and the control HRQOL by comparing child (CHQ-CF87) and parent (CHQ-PF50) reports for the nine scales for which the child and parent versions have common constructs or domains [30, 31] . Correlations between different methods (CHQ-CF87 vs. CHQ-PF50) should be higher if they are assessing the same HRQOL domain compared with when they are assessing different domains.
We assessed construct validity of the child and parent versions of CHQ for epilepsy by evaluating child and parent report of HRQOL for the cases with more severe disease compared with those with less severe disease as reflected by their 5-year remission status, current AED use, having complicated epilepsy or not, whether the epilepsy met the criteria for pharmacoresistant and whether the child had not been seizure-free for the prior 5 years. Only study participants whom the HRQOL was evaluated for both the case and the parent were included in this analysis (n = 279). We evaluated differences in mean HRQOL scores for the cases that were seizure-free versus not seizure-free, taking AEDs versus not taking AEDs, complicated versus not complicated, and were currently pharmacoresistant versus not pharmacoresistant using t-tests for both the child and parent report.
Analyses were performed using Stata (9.2; StataCorp LP, College Station, TX), SAS (9.1; SAS Institute, Cary, NC), and the MTMM.exe program (Santa Monica, CA) [31] . We used an a priori p value of P Յ 0.05 for statistical significance.
Results
Sociodemographic and Clinical Characteristics
Sociodemographic and clinical characteristics for children, sibling controls, and parents are shown in Table 1 . The CHQ was completed for both the case and the parent but with no sibling control in 279 dyads. For the 143 cases, the CHQ was also completed by sibling control, and the same parent rated HRQOL in these 143 case-control pairs. There was no significant difference in the parent-child testing dates between the cases and the controls (P = 0.59).
Internal Consistency Reliability
Cronbach's alphas were high, ranging from 0.75 to 0.90 for CHQ-CF87 the subscales (Table 2 ) and from 0.74 to 0.97 for the CHQ-PF50 subscales (Table 3) . Because the CHQ-CF87 has been recommended for ages 10 and over, we analyzed internal consistency reliability for the subset of children aged 9 and under (cases n = 18; controls n = 28). Cronbach's alpha for all the scales except one exceeded 0.80; Cronbach's alpha was 0.69 for one scale, general health perceptions.
Comparison of Child versus Parent Report of HRQOL Using Matched Sibling Controls
There were no differences between the self-reported case and the control HRQOL scores on 9 of the 11 scales and 2 global items of the CHQ-CF87 ( Table 2, Fig. 1a) . The cases reported worse HRQOL than the controls on the two scales: physical function (P = 0.01) and role limitations-physical (P = 0.04). In contrast, parent-report of HRQOL for the controls was significantly better than cases on 10 of the 12 scales, 2 global items, and both summary scores of the CHQ-PF50 (all P Յ 0.05) ( Table 3 , Fig. 1b) . Excluding the 29 complicated cases from our analyses, the findings were similar except that the child and the sibling control self-reports of HRQOL were now no different on all 11 CHQ-CF87 scales, and parent report of the case and the sibling control HRQOL was still significantly better on 10 of the 12 scales, both summary scores, and only 1 global item (global general health).
Compared with age-adjusted norms, parent report of the case HRQOL was significantly lower for only 3 of the 12 scales (P Յ 0.01), although parent report of control HRQOL was significantly higher for 7 scales and both summary scores (P Յ 0.01) with the exception of one scale, family activities, which was significantly lower (P Յ 0.05) ( Table 3) . Similar results were found for parent report of the case and the control HRQOL compared with gender-adjusted norms (results not shown).
Parent-Child Agreement
Parent-child agreement was low for the single items with the same wording between the CHQ-CF87 and CHQ-PF50. Weighted kappas ranged from 0.27 to 0.33 for the case-parent and 0.27 to 0.28 for the control-parent. MTMM analysis showed relatively poor agreement between parent and child on common domains. The average correlation between parent and child when reporting on the same HRQOL domains was a little higher for the cases (r = 0.374) than the controls (r = 0.334), but the average correlation was also higher when they were reporting on different domains (r = 0.285 vs. r = 0.246). Evidence for construct validity was low; only 82 out of the 288 (case) and 98 out of the 288 (control) t-tests of the different pairs of MTMM discriminant validity correlations were significant in the hypothesized direction.
Construct Validity of Child versus Parent Report of HRQOL of Case (Child with Epilepsy) by Disease Severity
In contrast to child self-report, where HRQOL was only infrequently associated with 5-year remission status, AED use, and having complicated epilepsy, parent report of the case HRQOL was often significantly associated with CHQ-PF50 scales (Table 4) . For example, parent-reported HRQOL for the seizurefree (n = 178) cases was significantly better compared with the nonseizure-free (n = 101) cases in 7 scales, 2 global items, and both summary scores (P Յ 0.03). In contrast, both parents' and children's ratings of the child's HRQOL were significantly asso-ciated with pharmacoresistance status for about half the HRQOL scales on the child and on the parent versions (Table 4) .
Discussion
The measurement of HRQOL is more complex in children compared with adults; the assessment of child HRQOL often relies on a parent or guardian report. Children, however, may have different perspectives from that of their adult proxies. We found significant differences in child self-report versus parent report of HRQOL for children with epilepsy compared with sibling controls. Overall, children with epilepsy report HRQOL that is comparable with that of healthy sibling controls while parents rated children with epilepsy as having lower or worse HRQOL Fig. 1a ). Sensitivity analysis excluding 29 complicated cases resulted in similar findings except that the child and the sibling self-reports of health-related quality of life (HRQOL) were no different on all CHQ-CF-87 scales. Note: All HRQOL scale scores range from 0 (worst) to 100 (best).
than sibling controls broadly across multiple scales, with no predominance of one domain. These results suggest children and parents may not necessarily share similar views about the overall impact of epilepsy. There are several potential explanations for our findings. First, the concerns of a child with epilepsy may differ from that of a parent. For example, Arunkumar et al. reported that out of 26 identified concerns about living with epilepsy, children identified 5 domains that were not identified by parents (hatred of seizures, dislike of hospital visits, dating, social embarrassment, and headache) [32] . In this regard children and parents may draw on different values and perspectives from which to evaluate HRQOL. Children and parents, however, may not be aware of these different perspectives [33] . Second, it is likely that parent report of HRQOL for children with epilepsy is influenced by parental anxiety that could lead to a lower or worse parent report of HRQOL compared with the child report. Parental anxiety may stem from the knowledge that children with epilepsy face many challenges including, but not limited to seizures, including behavior, psychiatric, learning, and school performance problems [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] , in addition to poor long-term outcomes with respect to employment, educational attainment, socioeconomic status, marital status, and QOL [34] [35] [36] [37] . In fact, parents are highly aware of the behavioral, emotional, and cognitive difficulties faced by their children with epilepsy [38] . Parental anxiety was found to be significantly associated with decreased QOL for children with epilepsy in a study by Williams et al. in which parent ratings of QOL were measured using the Impact of Childhood Illness Scale [39] . Lastly, having a chronic disease, or disability, does not necessarily mean that a person is unsatisfied with their life, despite what others may think-a term denoted the disability paradox [40] . Such a paradox could explain our findings that parent report of HRQOL was low compared with child report. In this regard, parental perception of HRQOL may be distorted because of having a "sick" child; such distortion could not only lead to an underestimate of the HRQOL of the child with epilepsy, but also, it may result in an overestimate of the HRQOL of a "healthy" sibling-a phenomenon that could explain our findings that parents viewed sibling controls as having better HRQOL than general population controls.
Our findings are consistent with prior research, which has suggested that parents of children with health conditions tend to underestimate the child's HRQOL [41] . In fact, parent report of lower or worse HRQOL compared with child report has been observed in a number of different disease states including cancer, asthma, diabetes, inflammatory bowel disease, and attentiondeficit disorder [12, 22, [42] [43] [44] [45] . Few studies, however, have evaluated parent child differences in the report of HRQOL in children with epilepsy [19, 20, 22] . Verhey et al. found that parents rated children's HRQOL lower compared with the child's report as measured by an epilepsy-specific measure, the CHEQOL-25 [19] . Only a small proportion of children in this sample, however, was seizure-free (11.5% seizure-free for 12 months). In contrast, our sample uniquely identifies these parent-child differences in a sample of children with predominantly well-controlled epilepsy (>60% were seizure-free for 5 years). Furthermore, although Hamiwka et al. reported child-parent differences in a sample of first-time seizure patients, this study was limited by the fact that comparisons were made with different parent and child normative samples; the CHQ-CF87 norms were based on an Australian normative sample, while the CHQ-PF50 norms were based on a US normative sample [20] . Additionally, Felder-Puig et al. found that parent report of HRQOL was lower compared with the child report of HRQOL using a German version of the generic PedsQL [22] . Nevertheless, the epilepsy sample in this study was small (n = 41) and no clinical information was provided regarding epilepsy disease severity (seizure frequency or remission status). Finally, in a sample of adolescents with epilepsy, Huberty et al. found that adults (parents and teachers) tended to agree with each other than with youths, with youths reporting fewer problems than adults [21] . Although analogous to our findings, the Hubert study focused on analyzing different informant perspectives of behavior, while we analyzed differences in perspectives on HRQOL.
There are several limitations to our study. First, because the CHQ is a generic instrument, it may not be sensitive to the nuances of epilepsy. Although published data are available evaluating the use of the CHQ-PF50 in a sample of children who underwent resective epilepsy surgery, no such data are available for the CHQ-CF87 [25] . As such, the differences that we found 51.0*** *Significant differences between cases and controls observed means P Յ 0.05 (see Fig. 1b ). Significant differences between cases or controls observed means and age-adjusted norms, **P Յ 0.05; ***P Յ 0.01; ****P Յ 0.0001. Note: All HRQOL scale scores range from 0 (worst) to 100 (best), except for the physical and psychosocial summary scores, which are T-scores (mean = 50, SD = 10) calculated against a reference population (Landgraf, 1996) . Sensitivity analysis excluding 29 complicated cases resulted in similar findings except that global behavior no longer significantly different.
may reflect our finding of better construct validity for epilepsy disease severity in the CHQ-PF50 compared with the CHQ-CF87, perhaps suggesting that parent reports are more valid than child self-reports in this population. Second, the CHQ-CF87 and the CHQ-PF50 have varied item wording and scale length, making direct comparisons of agreement across the measures problematic; we did, however, find low parent-child agreement on the three items with the same wording between parent and child versions [41] . Furthermore, our comparison of child and parent report of HRQOL with that of a sibling control, however, allows for indirect comparisons between the child and parent versions. Third, although the CHQ-CF87 is primarily intended for administration in children ages 10 to 18 years, we included children under age 10 (18% cases and 28% sibling controls in the matched case-control sample). Internal consistency reliability for the subsample, however, was high (Cronbach's alpha Ն0.80 for all but one scale). Fourth, although we noted statistically significant differences on multiple domains of HRQOL in the parent report of the case compared with the sibling control-only differences in seven of the scales (role/social limitations-physical, role/social limitations-emotion/behavior, behavior, general health perceptions, family activities, parent impact on time, parent emotional impact) and the one global general health item may represent clinically meaningful differences (>five points) [25] . Furthermore, we did not correct for multiple comparisons, although we used an a priori P-value of P Յ 0.05 for statistical significance; nevertheless, we note that the outcomes (dependent variable) are correlated, and a strict adjustment would be too conservative. Lastly, the generalizability of our findings may be limited not only because we were only able to compare the CHQ-PF50 with normative data because there is no US-based normative data for the CHQ-CF87, but also because our sample population was relatively homogeneous; the subjects were recruited from only one US state (Connecticut), Figure 1 The sibling control health-related quality of life (HRQOL) scores minus the case HRQOL scores for (a) child self-report (CHQ-CF87), and (b) parent report (CHQ-PF50). The (a) cases reported worse HRQOL than the controls on only 2 scales, while (b) parent report of HRQOL for the controls was significantly better than the cases on 10 or 12 scales, 2 global items, and both summary scores of the CHQ-PF50. Sensitivity analysis excluding 29 complicated cases resulted in similar findings except that child and sibling self-reports of HRQOL were no different on all CHQ-CF87 scales while parent report of case and sibling control HRQOL was still significantly better on 10 of the 12 scales, both summary scores, and only 1 global item (global general health). CHQ, Child Health Questionnaire. 
<0.0001
Summary scores (T-scores) Physical summary score Pharmacoresistance is defined as failure of two different appropriate antiepileptic drugs to bring seizures under complete control when used as prescribed and pushed to the maximum tolerated levels. Current pharmacoresistance was defined as those 33 patients who were pharmacoresistant and not seizure-free for 5 years at the time of the 8-to 9-year follow-up assessment.These 33 patients were compared with the other 246 patients who were never pharmacoresistant (regardless of whether or not they were seizure-free for 5 years) or who had been pharmacoresistant in the past but had been seizure-free for 5 years at the 8-to 9-year follow-up assessment. Note:All HRQOL scale scores range from 0 (worst) to 100 (best), except for the physical and psychosocial summary scores, which are T-scores (mean and were predominantly Caucasian (>80%), and highly educated (43% of the parents had college education or higher). The predominance of subjects with relatively high socioeconomic status in our sample, however, may explain our finding that parent report of HRQOL for the sibling control was higher compared with normative data. This study uniquely showed differences in parent and child report of HRQOL in a prospective, community-based sample of children with predominantly well-controlled epilepsy compared with sibling controls. Because parent ratings are often used to assess HRQOL in children, it is important to understand that children and parents may have different perspectives, both of which need to be taken into account when assessing HRQOL. Patient-reported outcomes, including HRQOL, are increasingly being recognized as an important outcome measure in research studies, particularly in clinical antiepileptic medication trials and prospective studies evaluating surgical outcomes. Furthermore, the evaluation of HRQOL is essential for developing disease management programs for children and families with epilepsy that not only provide comprehensive treatment and education, but also help facilitate dialog between parents and children given the different perspectives that each may have. Understanding the potential different, yet valuable, perspectives provided by parents and children is integral to these evaluations and also for developing appropriate support services targeted for children as they transition into adulthood. As such, future studies are needed to further validate our findings and to elucidate the factors that may drive these potential differences.
